Text Size

Telephone Enhancement Procedure for Continuing Care - 1

This study has been completed.
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00067171
First received: August 12, 2003
Last updated: April 13, 2010
Last verified: April 2010
History of Changes
  Purpose

The purpose of this study is to test a feasibility study of a telephone enhancement procedure (TELE) to improve participation in continuing care activities.


Condition Intervention Phase
Substance-Related Disorders
 Behavioral: Behavior Therapy
 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Official Title: Telephone Enhancement Procedure (TELE) for Continuing Care

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Treatment compliance, drug and alcohol astinence

Estimated Enrollment: 339
Study Start Date: January 2003
Study Completion Date: January 2004
Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Residential substance abuse treatment patients who reside within the pre-specified catchment area who complete continuing care plans prior to discharge.
  • Voluntary admit to residential treatment center; substance abuse or dependence; reside in targeted counties; and may be reached by telephone.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00067171

Locations
United States, Michigan
James Gilmore Jr. Treatment Center
Kalamazoo, Michigan, United States, 49408
United States, North Carolina
Julian F. Keith
Black Mountain, North Carolina, United States, 28711
Walter B. Jones, ADATC
Greenville, North Carolina, United States, 27834
United States, South Carolina
Morris Village Alcohol & Drug Treatment Center
Columbia, South Carolina, United States, 29203
Sponsors and Collaborators
Duke University
Investigators
Principal Investigator: Robert Hubbard, Ph.D. Duke University
  More Information

Additional Information:
Data Elements  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Robert Hubbard, Ph.D., Duke University
ClinicalTrials.gov Identifier: NCT00067171     History of Changes
Other Study ID Numbers: NIDA-CTN-0011-1
Study First Received: August 12, 2003
Last Updated: April 13, 2010
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 19, 2013